Newsroom

News and safety alerts

868 items

Announcements, product safety communications and regulatory updates.

Safety Alerts

Sorafenib: Risk of Thrombotic Microangiopathy (TMA)  

Overview Sorafenib is a multiple tyrosine kinase inhibitor (TKI) that reduces tumour cell proliferation and angiogenesis and induces tumour cell apoptosis.1-2 Sorafenib is indicated for the treatment…

Announcement Main

Laporan Kajian Kepuasan Pelanggan (Luar) NPRA Tahun 2022

Tuan / Puan, Sepertimana tuan / puan sedia maklum, Bahagian Regulatori Farmasi Negara (NPRA) telah menjalankan Kajian Kepuasan Pelanggan dari 1 Februari 2022 sehingga 30 April 2022 (3 bulan). Kajian…

Document attached

MedSafetyWeek

๐Ÿ˜Š Thank you for joining #MedSafetyWeek ๐Ÿ’Š

๐Ÿ˜Š This is the last day of #MedSafetyWeek ๐Ÿ’Š but we still need your help to make medicines safer for everyone ๐Ÿค ๐Ÿ˜Š Ini adalah hari terakhir #MedSafetyWeek ๐Ÿ’ŠWalau bagaimanapun kami masih memerlukan…

Document attached

MedSafetyWeek

๐Ÿ˜Š Hey, are you a pharmacist? ๐Ÿ’Š

Are you a pharmacist? Adakah anda seorang ahli farmasi? You are the first person patients go to when they have questions about their medicines. You can give patients helpful advice to prevent or…

Document attached

MedSafetyWeek

Why do We Monitor the Safety of Medicines?๐Ÿ”Ž

All medicines may cause side effects, reporting them saves lives. ๐Ÿ’Š That is why we monitor the safety of medicines, it protects patients from harm. Your help is crucial, so we can keep watch and make…

Document unavailable